成人超级难治性癫痫持续状态的多中心生酮饮食I/II期研究
该前瞻性多中心研究纳入15例成人超级难治性癫痫持续状态(SRSE)患者,采用经胃造瘘管经典生酮饮食(KD)方案。KD相关副作用包括代谢性酸中毒、高脂血症等。结论认为KD在成人SRSE中可行,可能安全有效,但需随机对照试验验证。
要点
- 成人SRSE患者经胃造瘘管生酮饮食可行,中位2天达到酮症。
- 常见副作用包括代谢性酸中毒、高脂血症、便秘、低血糖等。
核心结论
- 生酮饮食在成人SRSE中可行,可能安全有效,但需随机安慰剂对照试验确立比较性安全性与有效性。
主要发现
- 15例患者中位年龄47岁(四分位距30岁),5例(33%)为男性。
- KD前中位抗癫痫药物数为8种(四分位距7种),SRSE中位病程10天(四分位距7天)。
- 所有患者在中位2天(四分位距1天)内达到酮症。
- 5例(33%)最终死亡。
关键数值与推荐
- 主要结局指标为尿和血清酮体显著产生,作为可行性的生物标志物。
- 次要指标包括SRSE缓解、出院去向、KD相关副作用及长期结局。
- 副作用包括代谢性酸中毒、高脂血症、便秘、低血糖、低钠血症和体重减轻。
临床怎么用
- 对成人SRSE可考虑经胃造瘘管经典生酮饮食作为辅助治疗,需监测酮症及代谢性酸中毒等副作用。
局限性
- 本研究为Class IV证据,样本量小(15例),缺乏随机对照,比较性安全性与有效性尚未确立。
- KD治疗延迟原因包括静脉丙泊酚使用、肠梗阻及初始在非参与中心接受治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the feasibility, safety, and efficacy of a ketogenic diet (KD) for superrefractory status epilepticus (SRSE) in adults. METHODS: We performed a prospective multicenter study of patients 18 to 80 years of age with SRSE treated with a KD treatment algorithm. The primary outcome measure was significant urine and serum ketone body production as a biomarker of feasibility. Secondary measures included resolution of SRSE, disposition at discharge, KD-related side effects, and long-term outcomes. RESULTS: Twenty-four adults were screened for participation at 5 medical centers, and 15 were enrolled and treated with a classic KD via gastrostomy tube for SRSE. Median age was 47 years (interquartile range [IQR] 30 years), and 5 (33%) were male. Median number of antiseizure drugs used before KD was 8 (IQR 7), and median duration of SRSE before KD initiation was 10 days (IQR 7 days). KD treatment delays resulted from intravenous propofol use, ileus, and initial care received at a nonparticipating center. All patients achieved ketosis in a median of 2 days (IQR 1 day) on KD. Fourteen patients completed KD treatment, and SRSE resolved in 11 (79%; 73% of all patients enrolled). Side effects included metabolic acidosis, hyperlipidemia, constipation, hypoglycemia, hyponatremia, and weight loss. Five patients (33%) ultimately died. CONCLUSIONS: KD is feasible in adults with SRSE and may be safe and effective. Comparative safety and efficacy must be established with randomized placebo-controlled trials. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that in adults with SRSE, a KD is effective in inducing ketosis.
引用
- Cervenka MC, Hocker S, Koenig M, et al. Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology. 2017. PMID: 28179470. doi:10.1212/WNL.0000000000003690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。